Dr. med. Franziska Erlmeier

Institute of Pathology

Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations (2024) Mikuteit M, Zschäbitz S, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F Journal article Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma (2023) Erlmeier M, Mikuteit M, Zschaebitz S, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F Journal article The role of claudin-6 in chromophobe renal cell carcinoma (2023) Erlmeier F, Zschäbitz S, Mikuteit M, Autenrieth M, Weichert W, Hartmann A, Steffens S Journal article Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities (2023) Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, et al. Journal article Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma (2023) Mikuteit M, Zschäbitz S, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Expression of nectin-4 in papillary renal cell carcinoma (2022) Zschabitz S, Mikuteit M, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas (2022) Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, et al. Journal article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification. (2022) Prade VM, Sun N, Shen J, Feuchtinger A, Kunzke T, Buck A, Schraml P, et al. Journal article, Letter